CDC alerts to increasing RSV cases in infants, babies.
Warning: Respiratory Syncytial Virus Cases on the Rise
The Centers for Disease Control and Prevention (CDC) is sounding the alarm on a surge in respiratory syncytial virus (RSV) cases across parts of the Southeastern United States. This recent increase indicates a return to the seasonal RSV trends seen before the COVID-19 pandemic.
According to the CDC, regional spikes in RSV cases have historically signaled the start of the national RSV season, with the virus spreading north and west over the next few months. While RSV levels have been rising since July, nationwide test positivity has remained below the season onset threshold of 3 percent for two consecutive weeks.
However, recent data from Florida show an upward trend in test positivity since late July, with the three-week moving average exceeding 5 percent for the past month. Georgia has also experienced an increase in RSV-related hospitalizations in August, particularly among children aged 4 and younger.
In response to this concerning trend, the CDC is urging clinicians to prepare for the upcoming 2023–2024 RSV season by considering new prevention options. These options include administering monoclonal antibody products and a preventative antibody treatment called nirsevimab.
A human respiratory syncytial virus, also known as RSV, shown in a 1981 electron microscope image. (Centers for Disease Control and Prevention via AP)
FDA Approves RSV Treatments
For all infants ages
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
Now loading...